Iron Accumulation Is Not Homogenous among Patients with Parkinson's Disease

被引:31
作者
Dashtipour, Khashayar [1 ]
Liu, Manju [2 ]
Kani, Camellia [1 ]
Dalaie, Pejman [1 ]
Obenaus, Andre [3 ]
Simmons, Daniel [1 ]
Gatto, Nicole M. [4 ]
Zarifi, Andmehran [1 ]
机构
[1] Loma Linda Univ, Sch Med, Dept Neurol, Loma Linda, CA 92354 USA
[2] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI 48202 USA
[3] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92354 USA
[4] Loma Linda Univ, Sch Publ Hlth, Ctr Nutr Hlth Lifestyles & Dis Prevent, Loma Linda, CA 92354 USA
关键词
BRAIN IRON; SUBSTANTIA-NIGRA; DEPOSITION; SWI;
D O I
10.1155/2015/324843
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Iron is considered to lead to neurodegeneration and has been hypothesized as a possible cause of Parkinson's disease (PD). Susceptibility-weighted imaging (SWI) is a powerful tool to measure phase related iron content of brain. Methods. Twelve de novo patients with PD were recruited from the Movement Disorders Clinic, Department of Neurology, Loma Linda University. Twelve age-and sex-matched non-PD subjects were recruited from neurology clinic as controls. Using SWI, the phase related iron content was estimated from different brain regions of interest (ROIs). Results. There was a trend between increasing age and iron accumulation in the globus pallidus and putamen in all subjects. Iron accumulation was not significant in different ROIs in PD patients compared to controls after adjustment for age. Our data revealed heterogeneity of phase values in different brain ROIs among all subjects with an exaggerated trend at SN in PD patients. Conclusions. Our data suggest a nonhomogeneous pattern of iron accumulation in different brain regions among PD patients. Further studies are needed to explore whether this may correlate to the progression of PD. To our knowledge, this is the first study demonstrating the heterogeneity of iron accumulation in the brain, among patients with PD.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration [J].
Ayton, Scott ;
Lei, Peng .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[2]   MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects [J].
Bartzokis, G ;
Cummings, JL ;
Markham, CH ;
Marmarelis, PZ ;
Treciokas, LJ ;
Tishler, TA ;
Marder, SR ;
Mintz, J .
MAGNETIC RESONANCE IMAGING, 1999, 17 (02) :213-222
[3]   Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease [J].
Baudrexel, Simon ;
Nuernberger, Lucas ;
Rueb, Udo ;
Seifried, Carola ;
Klein, Johannes C. ;
Deller, Thomas ;
Steinmetz, Helmuth ;
Deichmann, Ralf ;
Hilker, Ruediger .
NEUROIMAGE, 2010, 51 (02) :512-520
[4]   THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS [J].
BENSHACHAR, D ;
ESHEL, G ;
FINBERG, JPM ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) :1441-1444
[5]   INTRANIGRAL IRON INJECTION INDUCES BEHAVIORAL AND BIOCHEMICAL PARKINSONISM IN RATS [J].
BENSHACHAR, D ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (06) :2133-2135
[6]   INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
WELLS, FR ;
LEES, AJ ;
AGID, F ;
AGID, Y ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836
[7]  
DRAYER B, 1986, AM J NEURORADIOL, V7, P373
[8]   Combined R2*and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease [J].
Du, Guangwei ;
Lewis, Mechelle M. ;
Styner, Martin ;
Shaffer, Michele L. ;
Sen, Suman ;
Yang, Qing X. ;
Huang, Xuemei .
MOVEMENT DISORDERS, 2011, 26 (09) :1627-1632
[9]   Iron as a cause of Parkinson disease - a myth or a well established hypothesis? [J].
Friedman, Andrzej ;
Galazka-Friedman, Jolanta ;
Koziorowski, Dariusz .
PARKINSONISM & RELATED DISORDERS, 2009, 15 :S212-S214
[10]   INCREASED IRON-RELATED MRI CONTRAST IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE [J].
GORELL, JM ;
ORDIDGE, RJ ;
BROWN, GG ;
DENIAU, JC ;
BUDERER, NM ;
HELPERN, JA .
NEUROLOGY, 1995, 45 (06) :1138-1143